recent stories from [features.blogs.fortune.cnn.com] on Twitter.
Ranbaxy - FORTUNE Features features.blogs.fortune.cnn.com 1 TWEETS
Fortune\'s news blog features content on personal finance, autos, technology, local and global company news, political opinions, entrepreneurs and business news, book reviews, and context on breaking news for investors.
No-show judge bolsters Chevron's attack on $19 billion judgment - Fortune Features features.blogs.fortune.cnn.com 47 TWEETS
The Ecuadorian judge who awarded the environment judgment against Chevron was a no-show witness for a deposition in Peru.
features.blogs.fortune.cnn.com/2013/05/17/judge-chevron-ecuador-2/
Can P&G make money in places where people earn $2 a day? - Fortune Features features.blogs.fortune.cnn.com 333 TWEETS
As Western companies duke it out for a piece of the developing-market pie, Procter & Gamble is going deeper -- courting not just the newly rich but also the very poor. The company's vaunted R&D operation is turning up surprises.
features.blogs.fortune.cnn.com/2011/01/06/can-pg-make-money-in-places-where-people-earn-2-a-day/
Dirty medicine - Fortune Features features.blogs.fortune.cnn.com 1 TWEETS
The epic inside story of long-term criminal fraud at Ranbaxy, the Indian drug company that makes generic Lipitor for millions of Americans.
features.blogs.fortune.cnn.com/2013/05/15/ranbaxy-fraud-lipitor/?source=linkedin
Dirty medicine - Fortune Features features.blogs.fortune.cnn.com 1 TWEETS
The epic inside story of long-term criminal fraud at Ranbaxy, the Indian drug company that makes generic Lipitor for millions of Americans.
features.blogs.fortune.cnn.com/2013/05/15/ranbaxy-fraud-lipitor/?src=longreads
Former Treasury official Frank Newman: Let's keep running big deficits - Fortune Features features.blogs.fortune.cnn.com 5 TWEETS
In his new book, Freedom From National debt, Frank Newman argues the U.S. shouldn't worry about its ballooning national debt.
features.blogs.fortune.cnn.com/2013/05/16/former-treasury-official-lets-keep-running-big-deficits/
Making money after the big sports contract ends - Fortune Features features.blogs.fortune.cnn.com 25 TWEETS
Mark Teixeira, Cal Ripken, Jr. and Randy Johnson made big money in Major League Baseball. Now they discuss the business ventures they’ve pursued outside of sports. FORTUNE -- Pro athletes are in denial.
features.blogs.fortune.cnn.com/2013/05/15/athletes-business-ventures/
Enron: The real story behind Jeff Skilling's big sentence reduction - Fortune Features features.blogs.fortune.cnn.com 16 TWEETS
The surprising news that former Enron CEO Jeff Skilling could get 10 years off his jail time results from years of legal wrangling.
features.blogs.fortune.cnn.com/2013/05/15/jeff-skilling-sentence-reduction-enron/
A $100 million plan to save our cities from the next Hurricane Sandy - Fortune Features features.blogs.fortune.cnn.com 6 TWEETS
The Rockefeller Foundation will hand out grants to cities that come up with ideas to limit damage from weather-related catastrophes.
features.blogs.fortune.cnn.com/2013/05/14/a-100-million-plan-to-save-our-cities-from-the-next-sandy/
Maker of generic Lipitor pleads guilty to selling 'adulterated drugs' - Fortune Features features.blogs.fortune.cnn.com 34 TWEETS
Ranbaxy Laboratories pleads guilty to seven criminal counts in Lipitor investigation.
Dirty medicine - Fortune Features features.blogs.fortune.cnn.com 1 TWEETS
The epic inside story of long-term criminal fraud at Ranbaxy, the Indian drug company that makes generic Lipitor for millions of Americans.
features.blogs.fortune.cnn.com/2013/05/15/ranbaxy-fraud-lipitor/?iid=H_F_News
Why Chevron's win in Canada might be big - Fortune Features features.blogs.fortune.cnn.com 26 TWEETS
A potentially lasting victory in the energy giant's $19 billion case. By Roger Parloff, senior editor FORTUNE -- On May 1, a Canadian judge handed Chevron a potentially major victory in an enforcement action brought against it by the Amazon Defense Front,
features.blogs.fortune.cnn.com/2013/05/03/why-chevrons-win-in-canada-might-be-big/
Actavis: What it's like to join the Fortune 500 - Fortune Features features.blogs.fortune.cnn.com 23 TWEETS
Generic pharmaceutical company Activis made its debut on the Fortune 500 this year at No. 432.
features.blogs.fortune.cnn.com/2013/05/10/actavis-what-its-like-to-join-the-fortune-500/
The hatred and bitterness behind the Adidas-Puma rivalry - Fortune Features features.blogs.fortune.cnn.com 80 TWEETS
The unbelievable story of the two brothers who started Adidas and Puma and wound up bitter enemies.
A better fingerprint scanner for frequent flyers - Fortune Features features.blogs.fortune.cnn.com 1 TWEETS
The company that supplies Global Entry, the government-run trusted traveler program, has begun production of a more user-friendly machine. Fortune -- Imagine that you step off a 15-hour international flight with plans to zip right through immigration than
features.blogs.fortune.cnn.com/2013/05/16/a-better-fingerprint-scanner-for-frequent-flyers/
Ranbaxy Laboratories knowingly sold inferior and dangerously contaminated generic drugs. When discussing the quality of AIDS drugs sold in Africa, an executive allegedly said, "Who cares? It's just blacks dying." features.blogs.fortune.cnn.com 1594 TWEETS
The epic inside story of long-term criminal fraud at Ranbaxy, the Indian drug company that makes generic Lipitor for millions of Americans.
features.blogs.fortune.cnn.com/2013/05/15/ranbaxy-fraud-lipitor/
Pickup trucks are back! - Fortune Features features.blogs.fortune.cnn.com 2 TWEETS
Suddenly pickups, the one-time profit engines for the Detroit 3, are firing on all cylinders again.
features.blogs.fortune.cnn.com/2013/05/07/pickup-trucks-are-back/
What to expect at the Shanghai auto show - Fortune Features features.blogs.fortune.cnn.com 1 TWEETS
The growth of the Chinese auto market is being fueled more and more by consumers who aren’t elite.
features.blogs.fortune.cnn.com/2013/04/18/shanghai-auto-show/?section=magazines_fortune
Ford and Toyota feud over whose is bigger - Fortune Features features.blogs.fortune.cnn.com 1 TWEETS
A quibble between Ford and Toyota over who's got the world's best selling car -- the Focus or the Corolla.
features.blogs.fortune.cnn.com/2013/04/15/ford-toyota-biggest/
